Independent Research GmbH Upgrades Pfizer (PFE) to Buy

Independent Research GmbH analyst Tobias Gottschalt upgraded Pfizer (NYSE: PFE) from Hold to Buy with a price target of $54.00 (from $51.00).

For an analyst ratings summary and ratings history on Pfizer click here. For more ratings news on Pfizer click here.

Shares of Pfizer closed at $49.02 yesterday.

You May Also Be Interested In

• New Street Research Upgrades Micron Technology (MU) to Buy
• Northland Upgrades Hyliion Holdings (HYLN) to Outperform 'on Improved Visibility to KARNO Commercialization'
• Wells Fargo Upgrades FOX Corp. (FOXA) to Overweight